ANRO
NYSE
$25.97
Alto Neuroscience Inc (ANRO)
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company is headquartered in Los Altos, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $35.13 (+35.27%)
Market Cap
$973M
Free Cash Flow Yield
-6.46%
Beta (5Y)
1.26
Price Chart
Valuation
Market Cap$973M
P/B4.44
Profitability
EBITDA-$77M
EPS-$2.43
Financial Health
Debt-to-Equity6.6%
Free Cash Flow Yield-6.46%
Growth & Risk
Beta (5Y)1.26
Sharpe Ratio2.22